56.67

10.39% -6.68

Hims Hers Health Inc (HIMS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HIMS Giù? Forum Previsione

Precedente Chiudi:

$63.35

Aprire:

$55.295

Volume 24 ore:

97.04M

Relative Volume:

2.13

Capitalizzazione di mercato:

$12.22B

Reddito:

$1.78B

Utile/perdita netta:

$164.40M

Rapporto P/E:

82.13

EPS:

0.69

Flusso di cassa netto:

$236.51M

1 W Prestazione:

-5.81%

1M Prestazione:

+18.32%

6M Prestazione:

+34.53%

1 anno Prestazione:

+218.22%

Intervallo 1D:

$54.70

$64.11

Intervallo di 1 settimana:

$54.70

$70.43

Portata 52W:

$13.47

$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Nome

Hims Hers Health Inc

Settore

Consumer Defensive (251)

Industria

Household & Personal Products (31)

Telefono

415-851-0195

Indirizzo

2269 CHESTNUT ST, SAN FRANCISCO

Dipendente

1,637

Cinguettio

Prossima data di guadagno

2025-02-24

Ultimi documenti SEC

HIMS's Discussions on Twitter

Confronta HIMS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HIMS Hims Hers Health Inc	56.73	14.00B	1.78B	164.40M	236.51M	0.69
PG Procter Gamble Co	150.77	352.82B	84.28B	15.97B	14.04B	6.51
UL Unilever Plc Adr	60.09	148.26B	65.76B	6.16B	0	2.4843
CL Colgate Palmolive Co	83.22	67.49B	19.95B	2.90B	3.47B	3.54
KMB Kimberly Clark Corp	134.24	43.34B	18.88B	2.43B	2.10B	7.26
KVUE Kenvue Inc	21.80	41.45B	15.30B	1.06B	1.45B	0.55

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-23	Downgrade	Needham	Buy → Hold
2025-06-04	Reiterato	Needham	Buy
2025-04-29	Downgrade	TD Cowen	Buy → Hold
2025-02-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Downgrade	Citigroup	Neutral → Sell
2025-01-07	Iniziato	BTIG Research	Buy
2024-12-17	Iniziato	Morgan Stanley	Overweight
2024-11-14	Downgrade	BofA Securities	Buy → Underperform
2024-08-22	Iniziato	Needham	Buy
2024-08-09	Downgrade	Imperial Capital	Outperform → In-line
2024-05-22	Downgrade	Citigroup	Buy → Neutral
2024-04-16	Downgrade	Jefferies	Buy → Hold
2024-04-10	Iniziato	Canaccord Genuity	Buy
2024-02-28	Aggiornamento	Imperial Capital	In-line → Outperform
2024-02-26	Iniziato	Leerink Partners	Market Perform
2023-12-07	Iniziato	Imperial Capital	In-line
2023-07-28	Iniziato	TD Cowen	Outperform
2023-04-11	Iniziato	Robert W. Baird	Neutral
2023-02-09	Aggiornamento	Jefferies	Hold → Buy
2022-11-08	Aggiornamento	BofA Securities	Neutral → Buy
2022-11-08	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Downgrade	Piper Sandler	Overweight → Neutral
2022-09-07	Iniziato	Truist	Hold
2022-07-15	Iniziato	SVB Leerink	Underperform
2022-04-14	Iniziato	Guggenheim	Buy
2022-04-01	Ripresa	Credit Suisse	Outperform
2022-03-10	Iniziato	Deutsche Bank	Hold
2021-12-02	Iniziato	Jefferies	Hold
2021-11-11	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-07-06	Iniziato	BofA Securities	Neutral
2021-05-20	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-04-21	Iniziato	Truist	Hold
2021-03-09	Iniziato	Credit Suisse	Neutral
2021-03-02	Aggiornamento	Citigroup	Neutral → Buy
2021-02-17	Iniziato	Citigroup	Neutral
2021-02-12	Iniziato	Piper Sandler	Neutral
2021-02-08	Iniziato	Tigress Financial	Buy

Mostra tutto

Hims Hers Health Inc Borsa (HIMS) Ultime notizie

01:02 AM

Wait Out The GLP-1 Storm – Buy The Hims And Hers Post-Earnings Dip (NYSE:HIMS) - Seeking Alpha

01:02 AM

12:09 PM

Hims & Hers Stock Is Trading Lower Tuesday: What's Going On? - Benzinga

12:09 PM

12:01 PM

Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire

12:01 PM

11:40 AM

HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down - Yahoo Finance

11:40 AM

11:25 AM

Palantir, Pfizer, Vertex, Hims & Hers, BP, and More Stock Market Movers - Barron's

11:25 AM

11:21 AM

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire

11:21 AM

11:11 AM

Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say - Benzinga

11:11 AM

11:07 AM

Hims & Hers stock slides 5% after second quarter revenue misses forecasts - Yahoo Finance

09:58 AM

09:51 AM

Hims & Hers Q2 EarningsWall Street Sells Despite GLP Compounding Promises (NYSE:HIMS) - Seeking Alpha

09:51 AM

09:14 AM

Hims & Hers: Mixed Q2 Results Signal Valuation Concerns - Trefis

09:14 AM

08:45 AM

Hims & Hers Stock Nosedives After Q2 Revenue Miss Despite 73% Growth - Yahoo Finance

08:45 AM

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire

08:45 AM

08:20 AM

Earnings live: Palantir stock pops on raised outlook, Hims & Hers tumbles - Yahoo Finance

08:20 AM

08:05 AM

Hold Rating for Hims & Hers Health Amid Mixed Results and Growth Investments - TipRanks

08:05 AM

07:30 AM

Hims & Hers: Buy The Earnings Dip, Slowly (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha

07:30 AM

06:50 AM

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On? - Benzinga

06:50 AM

03:44 AM

Avantax Advisory Services Inc. Sells 5,127 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World

03:44 AM

03:05 AM